batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Astellas pays $175m for a cautious Xtandi insurance plan 16 November 2023 Astra’s Pacific expansion plan hits the rocks 14 November 2023 On further review, KRAS inhibitors aren’t alike 13 November 2023 The first Emerald gleams for Astra 9 November 2023 Approval for the world’s twelfth VEGF drug 9 November 2023 Another PI3K inhibitor bites the dust 9 November 2023 More warnings signs for ATR inhibition 9 November 2023 Genmab deals another blow to CD37 8 November 2023 Load More